The latest idea in NAFLD/NASH pathogenesis

Area of Science:

• Hepatology and Metabolic Disorders
• Molecular Biology and Genetics

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a growing global health issue, driven by rising obesity and metabolic syndrome.
• NAFLD encompasses a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH), potentially leading to severe liver damage.
• Metabolic syndrome, characterized by obesity, impaired glucose and lipid metabolism, and hypertension, is strongly associated with NAFLD progression.

Purpose of the Study:

• To review the intricate mechanisms of lipid metabolism and hepatic steatosis in NAFLD/NASH.
• To explore the multifactorial pathogenesis of NAFLD/NASH, including genetic and lifestyle influences.
• To assess the role of oxidative stress and mitochondrial dysfunction in NASH development.

Main Methods:

• Literature review focusing on lipid metabolism pathways.
• Analysis of genetic factors, particularly PNPLA3 gene polymorphisms.
• Examination of the role of oxidative stress and free fatty acid metabolism.
• Investigation of mitochondrial function in NASH pathogenesis.

Main Results:

• Hepatic triglyceride accumulation can be protective against lipotoxicity, but excess free fatty acids drive hepatotoxicity via oxidative stress.
• Oxidative stress, exacerbated by mitochondrial abnormalities, is a critical factor in NASH pathogenesis.
• The PNPLA3 gene polymorphism is identified as a significant genetic determinant in NASH progression.

Conclusions:

• Hepatic lipid metabolism dysregulation and oxidative stress are central to NAFLD/NASH development.
• Genetic factors, such as PNPLA3, play a crucial role in disease progression.
• Further research into these molecular mechanisms is essential for therapeutic strategies against NAFLD/NASH.